Info@ThinkPinkRocks.com

Oncoceutics, MD Anderson partner to develop novel anti-cancer drug

Oncoceutics Inc. and The University of Texas MD Anderson Cancer Center today announced the initiation of a strategic alliance and research collaboration agreement for the clinical development of ONC201, a novel anti-cancer drug.

Read the original:
Oncoceutics, MD Anderson partner to develop novel anti-cancer drug

Share

Leave a Reply

Solve : *
20 + 28 =